MR
Madhavaram Ravinder Rao
About Madhavaram Ravinder Rao
Data last updated:
Madhavaram Ravinder Rao is a Director at Curewin-Hylico Pharma Private Limited (since 2018). The company operates in Pharma. Curewin-Hylico Pharma Private Limited reported revenue of ₹9.02 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curewin-Hylico Pharma Private Limited U51101TG2014PTC096702 | Director | 28 Apr 2018 | 2014 | ₹9.02 Cr (FY 2025) | Active |
Board colleagues of Madhavaram Ravinder Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babu Uttam Kumar Rao Julapalli | 07025748 | Curewin-Hylico Pharma Private Limited | Director |
| Srinivas Lagisetty | 06670295 | Curewin-Hylico Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Madhavaram Ravinder Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madhavaram Ravinder Rao
Madhavaram Ravinder Rao currently holds 1 directorship: Curewin-Hylico Pharma Private Limited (Director, since 28 Apr 2018, revenue ₹9.02 Cr (FY 2025)).
Madhavaram Ravinder Rao was first appointed on 28 Apr 2018 as Director at Curewin-Hylico Pharma Private Limited.
The current boards of Madhavaram Ravinder Rao's companies include Babu Uttam Kumar Rao Julapalli (Curewin-Hylico Pharma Private Limited), Srinivas Lagisetty (Curewin-Hylico Pharma Private Limited).